ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 716 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,615,528 | +1.4% | 23,856 | +7.2% | 0.08% | +4.1% |
| Q2 2023 | $1,593,077 | +6.3% | 22,259 | +3.1% | 0.07% | -1.4% |
| Q1 2023 | $1,498,007 | -3.5% | 21,582 | -5.8% | 0.07% | -6.3% |
| Q4 2022 | $1,552,756 | +21.2% | 22,902 | -2.0% | 0.08% | +11.3% |
| Q3 2022 | $1,281,000 | -16.3% | 23,362 | +0.9% | 0.07% | -11.2% |
| Q2 2022 | $1,530,000 | -0.3% | 23,151 | +0.1% | 0.08% | +14.3% |
| Q1 2022 | $1,534,000 | +1.0% | 23,128 | -11.3% | 0.07% | +6.1% |
| Q4 2021 | $1,519,000 | -9.6% | 26,076 | -6.8% | 0.07% | -16.5% |
| Q3 2021 | $1,680,000 | -3.4% | 27,969 | -3.7% | 0.08% | -2.5% |
| Q2 2021 | $1,740,000 | +11.3% | 29,046 | -7.6% | 0.08% | +5.2% |
| Q1 2021 | $1,563,000 | -13.2% | 31,441 | -12.8% | 0.08% | -22.2% |
| Q4 2020 | $1,801,000 | -16.8% | 36,036 | -8.8% | 0.10% | -26.1% |
| Q3 2020 | $2,165,000 | +2.6% | 39,508 | -1.0% | 0.13% | -2.2% |
| Q2 2020 | $2,110,000 | +10.9% | 39,896 | -6.4% | 0.14% | -6.2% |
| Q1 2020 | $1,903,000 | -21.2% | 42,605 | -12.1% | 0.15% | +9.8% |
| Q4 2019 | $2,416,000 | -0.4% | 48,448 | -10.9% | 0.13% | -8.3% |
| Q3 2019 | $2,425,000 | -17.8% | 54,398 | -23.9% | 0.14% | -19.0% |
| Q2 2019 | $2,951,000 | -10.2% | 71,484 | -12.0% | 0.18% | -12.3% |
| Q1 2019 | $3,286,000 | -6.4% | 81,269 | -12.1% | 0.20% | -17.4% |
| Q4 2018 | $3,511,000 | -6.2% | 92,456 | -2.2% | 0.25% | +10.8% |
| Q3 2018 | $3,742,000 | +1.6% | 94,561 | -9.8% | 0.22% | +3.2% |
| Q2 2018 | $3,682,000 | -0.1% | 104,873 | -0.5% | 0.22% | -5.3% |
| Q1 2018 | $3,685,000 | -3.5% | 105,390 | -4.2% | 0.23% | +5.6% |
| Q4 2017 | $3,817,000 | +10.3% | 109,995 | +6.4% | 0.22% | -4.0% |
| Q3 2017 | $3,460,000 | -6.3% | 103,352 | -4.5% | 0.22% | -7.0% |
| Q2 2017 | $3,692,000 | +4.1% | 108,217 | -5.0% | 0.24% | +3.4% |
| Q1 2017 | $3,546,000 | +1.8% | 113,868 | -10.7% | 0.23% | -1.3% |
| Q4 2016 | $3,483,000 | -24.4% | 127,503 | -6.4% | 0.24% | -27.1% |
| Q3 2016 | $4,605,000 | +13.2% | 136,175 | +1.1% | 0.32% | +11.3% |
| Q2 2016 | $4,068,000 | +11.1% | 134,749 | +3.6% | 0.29% | +9.4% |
| Q1 2016 | $3,662,000 | -17.7% | 130,056 | -0.3% | 0.27% | -18.8% |
| Q4 2015 | $4,448,000 | +10.8% | 130,492 | +3.5% | 0.33% | +6.5% |
| Q3 2015 | $4,013,000 | -2.0% | 126,111 | +96.2% | 0.31% | +10.8% |
| Q2 2015 | $4,096,000 | -5.6% | 64,291 | +1.4% | 0.28% | -6.1% |
| Q1 2015 | $4,341,000 | +9.3% | 63,432 | +12.4% | 0.30% | -5.7% |
| Q4 2014 | $3,972,000 | +10.1% | 56,439 | +11.8% | 0.32% | +1.9% |
| Q3 2014 | $3,606,000 | -1.0% | 50,475 | +3.0% | 0.31% | -1.9% |
| Q2 2014 | $3,643,000 | -2.0% | 49,027 | -14.4% | 0.32% | -7.1% |
| Q1 2014 | $3,718,000 | -7.1% | 57,304 | -15.0% | 0.34% | -13.1% |
| Q4 2013 | $4,002,000 | -39.3% | 67,415 | -46.9% | 0.39% | -47.1% |
| Q3 2013 | $6,593,000 | +4.9% | 126,954 | -4.5% | 0.74% | -6.1% |
| Q2 2013 | $6,285,000 | – | 132,883 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |